Is Microbix Biosystems (TSE:MBX) A Risky Investment?
Aug 15
Have your own idea? Try our Stock Screener
Canadian (TSX) Biotech Industry Analysis
UpdatedNov 19, 2025
DataAggregated Company Financials
Companies26
- 7D-1.7%
- 3M18.2%
- 1Y2.6%
- YTD4.0%
The Biotech is pretty flat in the last 7 days, but Helix BioPharma has stood out, gaining 11%. The past year has been better, since the industry has gained 3.8% in that time. In the next few years, earnings are forecast to decline by 9.4% annually.
Industry Valuation and Performance
Has the Canadian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 20 Nov 2025 | CA$2.3b | CA$93.4m | -CA$229,279,120.68 | 23x | -10x | 24.5x |
| Sat, 18 Oct 2025 | CA$2.3b | CA$95.7m | -CA$236,129,606.49 | 23.9x | -9.8x | 24.1x |
| Mon, 15 Sep 2025 | CA$1.7b | CA$95.6m | -CA$223,948,581.20 | 26.1x | -7.5x | 17.6x |
| Wed, 13 Aug 2025 | CA$1.6b | CA$91.2m | -CA$215,261,421.45 | 21.8x | -7.5x | 17.8x |
| Fri, 11 Jul 2025 | CA$1.6b | CA$91.0m | -CA$270,901,181.84 | 22.7x | -6x | 17.7x |
| Sun, 08 Jun 2025 | CA$1.5b | CA$90.6m | -CA$303,927,469.18 | 22.5x | -4.9x | 16.4x |
| Tue, 06 May 2025 | CA$1.5b | CA$92.9m | -CA$284,487,571.49 | 21.3x | -5.1x | 15.7x |
| Thu, 03 Apr 2025 | CA$1.5b | CA$85.7m | -CA$299,413,932.89 | 23x | -4.9x | 17.2x |
| Sat, 01 Mar 2025 | CA$1.5b | CA$88.7m | -CA$317,724,572.99 | 23.8x | -4.8x | 17.3x |
| Mon, 27 Jan 2025 | CA$1.5b | CA$87.5m | -CA$317,869,040.15 | 25.4x | -4.8x | 17.3x |
| Wed, 25 Dec 2024 | CA$1.4b | CA$85.6m | -CA$321,647,086.52 | 15.2x | -4.5x | 16.9x |
| Fri, 22 Nov 2024 | CA$1.3b | CA$83.2m | -CA$247,830,515.19 | 8x | -5.4x | 16.2x |
| Sun, 20 Oct 2024 | CA$1.6b | CA$80.4m | -CA$280,068,283.41 | 9x | -5.7x | 20x |
| Tue, 17 Sep 2024 | CA$957.5m | CA$80.3m | -CA$274,159,879.92 | 9.3x | -3.5x | 11.9x |
| Thu, 15 Aug 2024 | CA$941.6m | CA$75.2m | -CA$289,127,949.44 | 11.6x | -3.3x | 12.5x |
| Sat, 13 Jul 2024 | CA$1.1b | CA$76.1m | -CA$335,919,241.27 | 10.4x | -3.4x | 14.9x |
| Mon, 10 Jun 2024 | CA$1.2b | CA$76.9m | -CA$342,690,786.75 | 11.3x | -3.4x | 15.4x |
| Wed, 08 May 2024 | CA$960.9m | CA$78.8m | -CA$301,771,305.58 | 322.5x | -3.2x | 12.2x |
| Fri, 05 Apr 2024 | CA$988.8m | CA$88.1m | -CA$279,252,229.47 | 10.2x | -3.5x | 11.2x |
| Sun, 03 Mar 2024 | CA$1.2b | CA$91.6m | -CA$325,002,295.97 | 11.5x | -3.6x | 12.7x |
| Tue, 30 Jan 2024 | CA$3.6b | CA$87.8m | -CA$515,087,954.00 | 6.9x | -6.9x | 40.6x |
| Thu, 28 Dec 2023 | CA$3.6b | CA$86.1m | -CA$521,349,756.00 | 6.9x | -6.9x | 41.9x |
| Sat, 25 Nov 2023 | CA$3.9b | CA$86.4m | -CA$546,998,271.00 | 5.9x | -7.1x | 44.8x |
| Mon, 23 Oct 2023 | CA$3.8b | CA$89.0m | -CA$532,672,654.00 | 5.2x | -7x | 42.2x |
| Wed, 20 Sep 2023 | CA$3.9b | CA$88.8m | -CA$516,884,583.00 | 5.7x | -7.5x | 44x |
| Fri, 18 Aug 2023 | CA$4.0b | CA$87.3m | -CA$524,549,109.00 | 6.7x | -7.6x | 45.5x |
| Sun, 16 Jul 2023 | CA$4.1b | CA$81.5m | -CA$516,636,148.00 | 14.2x | -7.9x | 49.9x |
| Tue, 13 Jun 2023 | CA$3.9b | CA$86.5m | -CA$548,845,831.00 | 12x | -7.1x | 45.1x |
| Thu, 11 May 2023 | CA$3.8b | CA$82.3m | -CA$584,445,054.00 | 12.2x | -6.5x | 45.9x |
| Sat, 08 Apr 2023 | CA$2.3b | CA$84.3m | -CA$594,792,725.00 | 8.9x | -3.9x | 27.6x |
| Mon, 06 Mar 2023 | CA$2.7b | CA$90.4m | -CA$591,355,112.00 | 8.1x | -4.6x | 30.2x |
| Wed, 01 Feb 2023 | CA$3.0b | CA$86.4m | -CA$523,065,597.00 | 13.1x | -5.6x | 34.2x |
| Fri, 30 Dec 2022 | CA$3.0b | CA$87.6m | -CA$533,476,085.00 | 11.3x | -5.5x | 33.7x |
| Sun, 27 Nov 2022 | CA$3.1b | CA$88.4m | -CA$577,679,261.00 | 7.7x | -5.4x | 35.2x |
Price to Earnings Ratio
-5.4x
Current Industry PE
- Investors are relatively neutral on the Canadian Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 26.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that companies overall are more efficiently conducting business since losses are shrinking while sales have been flat.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare industry?
| CA Market | -1.66% | |
| Healthcare | -9.94% | |
| Biotech | -1.73% | |
| Biotech | -1.73% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HBP Helix BioPharma | CA$2.45 | 11.4% +CA$19.1m | 250.0% | PB12x | |
| MSCL Satellos Bioscience | CA$0.74 | 5.7% +CA$7.4m | -5.1% | PB2.5x | |
| DRUG Bright Minds Biosciences | CA$82.00 | 0.9% +CA$5.9m | 74.5% | PB12.3x | |
| NRX NurExone Biologic | CA$0.70 | 0% CA$5.7m | -7.9% | PB29.6x | |
| MDNA Medicenna Therapeutics | CA$1.44 | 4.3% +CA$5.0m | -4.0% | PB11.7x |